Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess between the renal impaired patients and normal renal
function subjects comparetive evaluation to Pharmacokinetics after CKD-501 Future, When
prescription CKD-501 to renal impaired patient, It will be guidelines to provide a basis of
instructions.